Find information on thousands of medical conditions and prescription drugs.

Trimetazidine

A drug for vertigo sometimes called Vastarel. Usually 0.020g per tablet.

Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, improves myocardial glucose utilization through inhibition of fatty acid oxidation.

It improves left ventricular function in diabetic patients with coronary artery disease.

It is described as the first cytoprotective anti-ischemic agent, acts by directly counteracting all the major metabolic disorders occurring within the ischemic cell. The actions of trimetazidine include limitation of intracellular acidosis, correction of disturbances of transmembrane ion exchanges, and prevention of excessive production of free radicals.

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

Oxytetracycline

Thiopental sodium

Tranexamic acid

Tranylcypromine

Triamcinolone hexacetonide

Triclabendazole

Trifluoperazine

Tubocurarine chloride

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]



	Bentley Pharmaceuticals Receives Approval to Market Trimetazidine in Spain; Antianginal Product Launch Planned for 2nd Quarter 2002 Business Editors, Health/Medical Writers NORTH HAMPTON, N.H.--(BUSINESS WIRE)--March 18, 2002 Bentley Pharmaceuticals, Inc. (AMEX: BNT), a specialty ... From Business Wire, 3/18/02

	Procoralan® , the First Pure Heart Rate-Lowering Agent, Receives Marketing Authorization in Europe Emea Approves New Treatment for Chronic Stable Angina PARIS, November 15 /PRNewswire/ -- Procoralan (ivabradine, Servier), the first selective and ... From PR Newswire, 11/15/05

	Two New Treatment Advances Coronary Artery Disease Patients STOCKHOLM, Sweden, September 6 /PRNewswire/ -- - EMEA gives go-ahead for Coversyl(R) (perindopril) indication in stable CAD and marketing authorisation ... From PR Newswire, 9/6/05

	Bentley Pharmaceuticals Fourth Quarter Revenue up 41% Y/Y to Record $11.5 Million Business Editors/Health/Medical Writers NORTH HAMPTON, N.H.--(BUSINESS WIRE)--Feb. 27, 2003 Bentley Pharmaceuticals, Inc.(AMEX:BNT): Year-end Revenue Jumps 48 % to Record $39.1 Million, Fue From Business Wire, 2/27/03

	Bentley Pharmaceuticals Reports Third Quarter Profitability On 37% Revenue Growth; Raises 2002 Revenue Guidance to $37 - $38 Million Business Editors & Health Writers NORTH HAMPTON, N.H.--(BUSINESS WIRE)--Oct. 30, 2002 Bentley Pharmaceuticals, Inc. (AMEX: BNT), a specialty pharmaceutical ... From Business Wire, 10/30/02

	Bentley Pharmaceuticals Reports Second Quarter Profitability On 65% Revenue Growth; Second Quarter Revenue Reaches a Record $10.1 Million Bentley Pharmaceuticals Reports Second Quarter Profitability On 65% Revenue Growth; Second Quarter Revenue Reaches a Record $10.1 Million. From Business Wire, 8/6/02

	Bentley Pharmaceuticals Expects Second Quarter Profitability On More Than $10 Million in Revenues Business Editors & Health/Medical Writers NORTH HAMPTON, N.H.--(BUSINESS WIRE)--July 25, 2002 Will Release 2nd Quarter Financial Results August 6th With Conference Call Scheduled for August 7 From Business Wire, 7/25/02

	Bentley Pharmaceuticals Reports First Quarter Profitability On 62% Revenue Growth Business Editors NORTH HAMPTON, N.H.--(BUSINESS WIRE)--April 30, 2002 -Operating Income Rises Over $1 million Before One-time Gains- -Raises 2002 ... From Business Wire, 4/30/02

Home

Contact

Resources

ebay